Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor II
Anti-Müllerian hormone receptor, type II (AMHR2), is a differentiation protein expressed in 90% of primary epithelial ovarian carcinomas (EOCs), the most deadly gynecologic malignancy. We propose that AMHR2 may serve as a useful target for vaccination against EOC. To this end, we generated the recom...
Saved in:
Main Authors: | Cagri Sakalar, Suparna Mazumder, Justin M. Johnson, Cengiz Z. Altuntas, Ritika Jaini, Robert Aguilar, Sathyamangla V. Naga Prasad, Denise C. Connolly, Vincent K. Tuohy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/630287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Mullerian Hormone: Usefulness in Clinical Practice
by: Kai J. Buhling, et al.
Published: (2013-01-01) -
The effect of anti mullerian hormone and follicle stimulating hormone discordance on oocyte quality and live birth rates
by: Seray Kaya, et al.
Published: (2024-04-01) -
Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01) -
Variability of anti-Müllerian hormone and folliculotropic hormone levels in women of reproductive age in relation to normal or impaired ovarian function
by: Małgorzata Jusiakowska-Piputa, et al.
Published: (2025-01-01) -
Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors
by: Maryna Krawczuk-Rybak, et al.
Published: (2013-01-01)